See more on Vaxcyte's (PCVX) and VAX-31’s broad pneumococcal vaccine pipeline, strong cash runway, and key 2026–2027 trial ...
Hantavirus pulmonary infection is a disease caused by some hantaviruses, not the Pfizer-BioNTech COVID-19 vaccine, contrary to widely shared online posts that misrepresented a document listing medical ...
Pfizer posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched and acquired products showed growth. Older top-selling drugs, including its ...
Lyme disease is the most common tick-borne infectious disease in the United States. There is no vaccine to protect against it in humans. Biopharmaceutical company Pfizer and Valne ...
There's actually nothing unusual going on with Pfizer's pharmaceutical business. The industry is highly competitive, capital-intensive, and driven by innovation. Unfortunately, research and ...
As Pfizer gears up to defend its patents on transthyretin amyloid cardiomyopathy (ATTR-CM) med tafamidis in court this week, eleventh-hour settlements with two of the three generic drugmakers involved ...
Pfizer’s $2.3 billion bet on Trillium Therapeutics doesn’t look like it will ever pay out, with the Big Pharma abandoning the second and final clinical-stage candidate from that acquisition. The ...
April 28 (Reuters) - Pfizer (PFE.N), opens new tab said on Tuesday it has settled ‌patent disputes with three generic drugmakers over its blockbuster heart drug Vyndamax, effectively extending its ...
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that it has entered into settlement agreements with generic drug manufacturers Dexcel Pharma, Hikma Pharmaceuticals and Cipla Ltd, ...
Arvinas and Pfizer are the first to take a PROteolysis TArgeting Chimera (PROTAC) therapy across the FDA finish line, opening the door to a new option for certain breast cancer patients. However, the ...
The agency’s scientists and data contractors reviewed millions of patient records for studies that were pulled back before release. By Christina Jewett Reporting from Washington Officials at the Food ...